Drugs / Low Titer Group O Whole Blood
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06070350 | Nov 2024 → Jun 2028 expected | — | Philip Spinella | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low Titer Group O Whole Blood | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06070350 ↗ |
| Known as | LTOWB | “LTOWB is whole blood from group O donors with low titer (\<200) anti-A and anti-B antibodies.” NCT06070350 ↗ |